# A Study in Healthy Adults to Assess Priming With Antigenically Mismatched Live Attenuated A/H7N3 Influenza Virus Vaccine Followed by Inactivated A/H7N9 Influenza Virus Vaccine

> **NCT03581903** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 20 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** H7N3 pLAIV
- **BIOLOGICAL:** H7N9 pIIV

## Key facts

- **NCT ID:** NCT03581903
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-19
- **Primary completion:** 2018-09-14
- **Final completion:** 2019-02-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03581903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03581903, "A Study in Healthy Adults to Assess Priming With Antigenically Mismatched Live Attenuated A/H7N3 Influenza Virus Vaccine Followed by Inactivated A/H7N9 Influenza Virus Vaccine". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03581903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*